Weave Communications (WEAV): What Does the Company Do? – Stock Outlook, Earnings, Market Cap, Related Stocks, and Headquarters Overview
Weave Communications (WEAV) is a SaaS company providing integrated AI-powered communication and payment solutions for small healthcare practices. With strong revenue retention and an expanding payments business, its earnings and stock price are closely linked, making it a notable healthcare IT growth stock drawing attention alongside its outlook and related names.
🏢 What kind of company is Weave Communications?
Weave Communications (WEAV) is a US-based healthcare IT software company. It offers a single cloud platform that integrates how small practices—such as dental, optometry, veterinary, and specialty medical offices—communicate with patients and manage appointments, payments, and reviews.
The company provides subscription-based software that bundles phone, text, and email communication, appointment reminders, patient forms, online reviews, and payment functionality into a single platform. It has built a strong position across dental, optometry, and veterinary verticals in the United States and Canada.
💰 How does Weave Communications make money?
| Business Segment | Revenue Share | Description |
|---|---|---|
| Subscription Software | Core | SaaS subscriptions for integrated communication, appointments, and reviews |
| Payments | Key Growth Driver | Transaction-based revenue from patient payment processing |
Recent revenue has continued to deliver stable double-digit growth. Subscription software accounts for the largest share of revenue, while the patient payment processing business is expanding rapidly as the key growth driver. Backed by high net revenue retention and a high share of recurring revenue, new customer wins continue to support the revenue trajectory, with operating profitability trending toward a breakeven inflection.
Weave Communications market cap and company sizeMarket capitalization stands at $584.8M, with an employee headcount of 904 people.
As a small-cap healthcare IT growth stock, the company is positioned as an integrated communication and payment platform specialized for small healthcare practices. Its overall market cap is in the small-to-mid range, and it belongs to a comparable group that includes PHR and DOCS within the same healthcare software segment. Because the company is still in the early stages of profitability, capital allocation is weighted toward reinvestment for growth rather than capital returns.
📈 Weave Communications outlook and stock price trends
Expansion of the payments business and AI-driven patient engagement and appointment automation are the core medium- to long-term growth drivers. Rising payments penetration per practice and entry into new verticals can lift revenue per customer. In the short term, the pace of new customer acquisition and any deceleration in revenue growth will drive stock price moves, and given the SMB customer base, new adoption could slow during macroeconomic downturns. Intensifying competition in the healthcare IT market and the speed of the path to profitability are additional sources of volatility.
- Rising penetration of patient payment processing
- Expansion of AI-based communication and appointment automation
- Entry into new verticals such as optometry, veterinary, and specialty medical practices
⚔️ Weave Communications core strengths and risks
Vertical specialization and high revenue retention create strong customer lock-in, while the speed of the path to profitability and the macroeconomic sensitivity of its small-business customer base are the key risks.
💪 Core Strengths
⚠️ Core Risks
🔄 Weave Communications competitors and related (beneficiary) stocks
In the directly comparable space, PHR, which provides patient engagement and payment software for medical practices, and DOCS, which offers clinician networks and digital marketing, form the peer healthcare IT group. Related names include GDRX, a prescription price comparison platform, and TDOC, a telemedicine provider, as part of the broader healthcare IT theme, along with ALKT and BL in the adjacent payments and subscription SaaS segment.
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| Phreesia Inc | $10.31 | +1.4% | $640.0M | 61.0 | 1.7 | 3.12% | - | |
| Doximity Inc | $25.58 | +3.5% | $4.6B | 30.3 | 5.0 | 17.21% | - |
| Ticker | Company | Price | Change | Market Cap | P/E | PBR | ROE | Dividend Yield |
|---|---|---|---|---|---|---|---|---|
| GoodRx Holdings Inc | $3.39 | +1.2% | $1.2B | 72.0 | 1.8 | 2.52% | - | |
| Teladoc Health Inc | $6.16 | +1.1% | $1.1B | - | 0.8 | -12.99% | - | |
| Alkami Technology Inc | $20.51 | +7.6% | $2.2B | - | 6.0 | -12.77% | - | |
| BlackLine Inc | $28.35 | -1.4% | $1.6B | 50.6 | 5.2 | 9.53% | - |
✅ Weave Communications investor checklist
Key points to monitor when investing in Weave Communications. Revenue growth trends, payments penetration, and the pace of the path to profitability are the key short- and medium-term variables, and the pace of new customer acquisition and revenue retention should also be tracked.
| Checklist | What to Verify | Current Status |
|---|---|---|
| Revenue Growth | Trend in subscription and payments revenue growth | Monitoring for any growth deceleration |
| Payments Penetration | Expansion of payment processing adoption per practice | On an expansion trajectory |
| Customer Retention | Trend in net revenue retention and churn | Maintained at a high level |
If the path to profitability is delayed beyond expectations, there is a risk of multiple compression for the growth stock. The small medical practice customer base is exposed to slower new adoption and higher churn during economic slowdowns, and intensifying healthcare IT competition can also pressure pricing and margins.
Weave is a growth stock offering integrated communication and payment SaaS specialized for small healthcare practices, with high revenue retention and payments expansion as its core growth drivers. However, given the meaningful exposure to the pace of profitability inflection and macroeconomic sensitivity, a phased buying approach with a long-term perspective is recommended.